Search Orphan Drug Designations and Approvals
-
Generic Name: | laminin-111 (human) |
---|---|
Date Designated: | 07/21/2011 |
Orphan Designation: | Treatment of Duchenne Muscular Dystrophy |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Prothelia, Inc. 30 Haven Street Milford, Massachusetts 01757 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-